Reverse stock split is a mechanical adjustment with no impact on fundamentals. Monitor for potential Nasdaq compliance benefit if the split lifts the stock price above the $1 minimum bid requirement, but no financial data was provided to assess current compliance status.
Price Chart
Executive Summary
Ping An Biomedical announced a 1-for-40 reverse stock split of its class A and class B ordinary shares, effective October 23, 2026. The consolidation reduces outstanding shares from ~112.9M class A and 12.3M class B to ~2.8M and 306K, respectively, with fractional shares rounded up. This is a routine capital structure adjustment with no fundamental business change.
Key Facts
- 1-for-40 reverse stock split approved by board on August 6, 2026, effective October 23, 2026.
- Outstanding class A shares will reduce from 112,867,000 to approximately 2,821,675.
- Outstanding class B shares will reduce from 12,250,000 to approximately 306,250.
- Par value changes from $0.0000625 to $0.0025 per share.
- Fractional shares will be rounded up to the next whole number.
- Ticker symbol PASW unchanged; new CUSIP G5880S139.
- Shareholder approval obtained at EGM on March 18, 2026.
Financial Impact
No change in aggregate market value or shareholder equity; purely mechanical share consolidation.
Risk Factors
- Reverse splits are often viewed negatively by the market as a signal of low stock price and potential delisting risk.
- Rounding up fractional shares creates minor dilution for existing holders.
- No financial or operational updates accompany this filing — the company's business outlook remains unclear.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-111243 |
| Document: ea030613201ex99-1.htm | 0001213900-26-111243 |
| Document: 0001213900-26-111243-index-headers.html | 0001213900-26-111243 |
| Document: 0001213900-26-111243-index.html | 0001213900-26-111243 |
| Document: 0001213900-26-111243.txt | 0001213900-26-111243 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $4.48 $4.88 | ▲ +8.93% | ▲ +8.37% | $4.88 (+8.93%) |
Oct 22, 2026 5d ago | 6-K | $4.76 $4.48 | ▲ +5.88% | ▲ +6.59% | $4.88 (−2.52%) |
Oct 22, 2026 5d ago | Press Release | $0.1340 $0.1190 | ▼ −11.19% | ▼ −10.67% | $4.88 (+3541.79%) |
Oct 21, 2026 6d ago | 6-K | $3.68 $5.40 | ▲ +46.85% | ▲ +48.03% | $4.88 (+32.61%) |
Sep 11, 2026 6w ago | 6-K | $0.1380 $0.1367 | ▲ +0.94% | ▲ +0.50% | $4.88 (−3436.23%) |
Jul 20, 2026 14w ago | 6-K | $0.1459 $0.1467 | ▲ +0.55% | ▼ −0.29% | $4.88 (+3244.76%) |
May 27, 2026 21w ago | 6-K | $0.1560 $0.1570 | ▼ −0.64% | ▼ −0.40% | $4.88 (−3028.21%) |
Feb 27, 2026 34w ago | EFFECT | $0.1490 $0.1430 | ▼ −4.03% | ▼ −4.08% | $4.88 (+3175.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers